Compare ATHM & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATHM | LGND |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | China | United States |
| Employees | N/A | 68 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2013 | 1992 |
| Metric | ATHM | LGND |
|---|---|---|
| Price | $23.39 | $188.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $28.00 | ★ $144.71 |
| AVG Volume (30 Days) | ★ 438.2K | 139.7K |
| Earning Date | 11-06-2025 | 08-05-2025 |
| Dividend Yield | ★ 10.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $951,436,680.00 | $181,488,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | $1.33 | $18.87 |
| P/E Ratio | $13.37 | ★ N/A |
| Revenue Growth | N/A | ★ 53.40 |
| 52 Week Low | $22.95 | $81.74 |
| 52 Week High | $32.70 | $129.90 |
| Indicator | ATHM | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 41.17 |
| Support Level | $23.16 | $192.71 |
| Resistance Level | $24.22 | $201.49 |
| Average True Range (ATR) | 0.62 | 6.95 |
| MACD | 0.06 | -2.50 |
| Stochastic Oscillator | 16.30 | 3.01 |
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.